Impact of Biological Agents on Postsurgical Complications in Inflammatory Bowel Disease: A Multicentre Study of Geteccu

Impact of Biological Agents on Postsurgical Complications in Inflammatory Bowel Disease: A Multicentre Study of Geteccu

Background: The impact of biologics on the risk of postoperative complications (PC) in inflammatory bowel disease (IBD) is still an ongoing debate. This lack of evidence is more relevant for ustekinumab and vedolizumab. Aims: To evaluate the impact of biologics on the risk of PC. Methods: A retrospe...

Full description

Bibliographic Details
Main Authors: María José García, Montserrat Rivero, José Miranda-Bautista, Iria Bastón-Rey, Francisco Mesonero, Eduardo Leo-Carnerero, Diego Casas-Deza, Carmen Cagigas Fernández, Albert Martin-Cardona, Ismael El Hajra, Nerea Hernández-Aretxabaleta, Isabel Pérez-Martínez, Esteban Fuentes-Valenzuela, Nuria Jiménez, Cristina Rubín de Célix, Ana Gutiérrez, Cristina Suárez Ferrer, José María Huguet, Agnes Fernández-Clotet, María González-Vivó, Blanca Del Val, Jesús Castro-Poceiro, Luigi Melcarne, Carmen Dueñas, Marta Izquierdo, David Monfort, Abdel Bouhmidi, Patricia Ramírez De la Piscina, Eva Romero, Gema Molina, Jaime Zorrilla, Cristina Calvino-Suárez, Eugenia Sánchez, Andrea Nuñez, Olivia Sierra, Beatriz Castro, Yamile Zabana, Irene González-Partida, Saioa De la Maza, Andrés Castaño, Rodrigo Nájera-Muñoz, Luis Sánchez-Guillén, Micaela Riat Castro, José Luis Rueda, José Manuel Benítez, Pedro Delgado-Guillena, Carlos Tardillo, Elena Peña, Santiago Frago-Larramona, María Carmen Rodríguez-Grau, Rocío Plaza, Pablo Pérez-Galindo, Jesús Martínez-Cadilla, Luis Menchén, Manuel Barreiro-De Acosta, Rubén Sánchez-Aldehuelo, María Dolores De la Cruz, Luis Javier Lamuela, Ignacio Marín, Laura Nieto-García, Antonio López-San Román, José Manuel Herrera, María Chaparro, Javier P. Gisbert, on behalf of the Young Group of GETECCU
Format: Article
Language:English
Published: MDPI AG 2021-09-01
Series:Journal of Clinical Medicine
Subjects:
inflammatory bowel disease
Crohn’s disease
ulcerative colitis
anti-TNF
ustekinumab
vedolizumab
Online Access:https://www.mdpi.com/2077-0383/10/19/4402

Internet

https://www.mdpi.com/2077-0383/10/19/4402

Similar Items